Calinogen Tablet 50 Units (Calidino-genase)

Adult dose

Administer 30-150 I.U. orally per day in 3 divided doses. Adjust the dose appropriately according to age and symptoms.

This medicine should not be used in patients with bleeding, such as immediately after a cerebral hemorrhage. Additionally, this medicine contains lactose, so it should not be administered to patients with genetic disorders that prevent lactose digestion. This medicine contains the dye Yellow No. 5, so caution is advised for those who have had allergies or hypersensitivity reactions to this component. When using this medication, hypersensitivity symptoms such as skin rash or itching may occur, and if such symptoms arise, it should be discontinued immediately. Symptoms of rapid heartbeat may rarely occur, and if such symptoms are experienced, healthcare professionals should be consulted. Gastrointestinal symptoms such as dyspepsia, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, and constipation may occasionally occur. Symptoms such as warmth, headache, drowsiness, and fatigue may also appear in some patients, thus requiring caution. In elderly patients, as physical functions may be weakened, the dosage should be reduced or taken with special care.

• Rash
• itching
• palpitations
• discomfort in the stomach
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medicine should be stored in a tightly closed container to prevent air and moisture ingress. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the effectiveness and safety of the medication over time.

Appearance

Orange round enteric-coated film tablets

Package unit

30 tablets/bottle, 300 tablets/bottle